Oh yes, I take “few weeks” Silviu words very cautiously. And anyway, the FDA were so keen to move this treatment forward they put a halt to further trials until msb fix their quality control problems… and then said go and do more trials.
Yep, that sounds like the FDA are wanting stems to roar ahead.
Frankly, you would do better to treat this company’s announcements with a bit more caution and actually look at what is going on.
Oh yes, I take “few weeks” Silviu words very cautiously. And...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
76.5¢ |
Change
-0.010(1.29%) |
Mkt cap ! $887.7M | |||
| Open | High | Low | Value | Volume |
| 76.5¢ | 80.3¢ | 76.0¢ | $5.022M | 6.472M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 425429 | 76.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 76.5¢ | 3903 | 1 |
View Market Depth
| Last trade - 16.10pm 19/04/2024 (20 minute delay) ? |
|
|||||
|
Last
76.5¢ |
Change
-0.010 ( 1.20 %) |
||||
| Open | High | Low | Volume | ||
| 78.0¢ | 80.0¢ | 76.0¢ | 2064486 | ||
| Last updated 15.59pm 19/04/2024 ? | |||||
| MSB (ASX) Chart |